Brick & Kyle Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTN
Raytheon Company
RTN
|
+$3.93M |
| 2 |
CVS Health
CVS
|
+$3.63M |
| 3 |
AWF
AllianceBernstein Global High Income Fund
AWF
|
+$903K |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$804K |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$795K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$3.16M |
| 2 |
Alerian MLP ETF
AMLP
|
+$1.57M |
| 3 |
SLB Ltd
SLB
|
+$934K |
| 4 |
L3Harris
LHX
|
+$927K |
| 5 |
CELG
Celgene Corp
CELG
|
+$825K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 14.69% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 14.15% |
| 4 | Consumer Discretionary | 13.45% |
| 5 | Communication Services | 12.42% |
Similar funds
Brick & Kyle Associates's Q2 2019 Portfolio in Review
As of Q2 2019, Brick & Kyle Associates held 75 positions worth $106M, up 8.7% from $97.5M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Brick & Kyle Associates deployed $4.49M of net new capital in Q2 2019, opening 11 new positions and adding to 21 existing holdings. Its largest new stake was Raytheon Company: 21,846 shares worth $3.73M.
By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Vanguard Morningstar Small-Cap ETF, an estimated $96K trimmed.
- Brick & Kyle Associates's largest Q2 2019 buy was Raytheon Company: 21,846 shares worth $3.73M.
- Brick & Kyle Associates added most to Chevron in Q2 2019, an estimated $583K increase.
- Brick & Kyle Associates's biggest Q2 2019 reduction was Vanguard Morningstar Small-Cap ETF, cutting an estimated $96K.
- Brick & Kyle Associates fully exited Zimmer Biomet in Q2 2019, selling an estimated $3.16M.
- Brick & Kyle Associates's ten largest holdings make up 44% of its $106M portfolio in Q2 2019.
- Brick & Kyle Associates opened 11 new positions and closed 8 in Q2 2019.
- Brick & Kyle Associates's portfolio value rose 8.7% quarter-over-quarter to $106M.
Based on Brick & Kyle Associates's 13F filing for Q2 2019, filed 17 Jul 2019.